Gold Mines Give Emergency Health Aid to Mali

JERSEY, CHANNEL ISLANDS--(Marketwire - Oct 31, 2012) -

TSX-V:IAE

RANDGOLD RESOURCES LIMITED
Incorporated in Jersey, Channel Islands
Reg. No. 62686
LSE Trading Symbol: RRS
NASDAQ Trading Symbol: GOLD

GOLD MINING COMPANIES IN MALI PROVIDE EMERGENCY FUNDING FOR FIGHT
AGAINST DISEASE

Bamako, Mali, 31 October 2012 - Gold mining companies in Mali will
donate USD735000 in emergency funding to avert an interruption of the
Mass Drug Administration (MDA) programme fighting a range of neglected
tropical diseases (NTDs) endemic to that country.

The donations by Randgold Resources, Avion Gold including personal
donations by its shareholders Forbes & Manhattan and executives John
Begeman and Don Dudek, AngloGold Ashanti, IAMGOLD, Resolute Mining,
Gold Fields and African Mining & Exploration, are being made to The End
Fund, a non-governmental organisation committed to providing access to
treatment for these NTDs.

The government of Mali is also effectively making a significant
donation through its shareholding in the various gold mining
operations. The development organisation Helen Keller International
will use these funds to support its partners in the mass distribution
of the drugs needed to treat these diseases without interruption.

Since the inception of the programme in 2007,with funding provided by
USAID, significant progress has been made in reducing the incidence,
prevalence and intensity of these diseases among Mali's population of
11million. However, the coup in Mali earlier this year prompted USAID
to suspend its funding,threatening continued implementation of the
treatment programme.

NTDs are a group of debilitating conditions, primarily found in
impoverished areas, which can cause blindness, chronic pain, severe
disability, disfigurement, and malnutrition. They reduce productivity
and can cripple the country's potential for social development and
economic growth. Although there are inexpensive, safe and effective
treatments available for NTDs, eradicating them requires consecutive
treatments and post-endemic surveillance for many years.

Click on, or paste the following link into your web browser, to view
the associated PDF document.

 http://www.rns-pdf.londonstockexchange.com/rns/0064Q_1-2012-10-31.pdf 

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END